GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Winshine Science Co Ltd (HKSE:00209) » Definitions » Net Change in Cash

Winshine Science Co (HKSE:00209) Net Change in Cash : HK$69.6 Mil (TTM As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Winshine Science Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Winshine Science Co's Net Change in Cash for the six months ended in Dec. 2023 was HK$80.5 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was HK$69.6 Mil.

Winshine Science Co Net Change in Cash Historical Data

The historical data trend for Winshine Science Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winshine Science Co Net Change in Cash Chart

Winshine Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.79 -33.14 11.66 -16.87 69.57

Winshine Science Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.70 -17.06 0.19 -10.98 80.55

Winshine Science Co Net Change in Cash Calculation

Winshine Science Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=9.487+-12.252+71.927+0.408
=69.6

Winshine Science Co's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=132.625+-8.704+-51.275+7.9
=80.5

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$69.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Winshine Science Co Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Winshine Science Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Winshine Science Co (HKSE:00209) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Winshine Science Co Ltd (HKSE:00209) » Definitions » Net Change in Cash
Comparable Companies
HKSE:00381 TSE:4661 HKSE:02020 LSE:CCL TSE:7309 TSE:7832 HAS AS HKSE:02331 MAT HKSE:09992 PLNT GOLF LSE:GAW SZSE:300144 TSE:7731 TSE:7951 YETI LTH PRKS
Traded in Other Exchanges
N/A
Address
287-299 Queen's Road, Room 1002, 10th Floor, 299 QRC, Central, Hong Kong, HKG
Website
http://www.winshine.com
Winshine Science Co Ltd is an investment holding company. The company's segment includes Securities investments, Toys, and Medical & health. It generates maximum revenue from the Toys segment. The toys segment derives its revenue from manufacturing for the sale of toys. The securities investments segment derives its profits or losses from dividends received from, and other gains or losses from, equity securities investments. The medical and health segment is under the development stage in which research and development expenses for medical and health technology development have been incurred. Its geographical segments are Hong Kong, China, the United States, Europe, and Korea, of which the majority of its revenue comes from the United States.
Executives
Wang Honggang 2101 Beneficial owner
U Credit (hk) Limited 2106 Person having a security interest in shares
Csc Holdings Limited 2106 Person having a security interest in shares
Hurray Talent Investment Development Limited 2101 Beneficial owner
Li Zhonghai 2201 Interest of corporation controlled by you
Liu Lian 2201 Interest of corporation controlled by you
Richsun Investment Development Limited 2101 Beneficial owner
Hong Kong Huiheng Trading And Investment Co., Limited 2101 Beneficial owner
Jiang Qinghui 2201 Interest of corporation controlled by you
Csc Holdings Limited (formerly Known As "china Strategic Holdings Limited") 2106 Person having a security interest in shares
China Strategic Holdings Limited 2106 Person having a security interest in shares
Shen Jia 2101 Beneficial owner

Winshine Science Co (HKSE:00209) Headlines

No Headlines